173 related articles for article (PubMed ID: 21761349)
1. Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogen.
Weroha SJ; Lingle WL; Hong Y; Li SA; Li JJ
Horm Cancer; 2010 Feb; 1(1):34-43. PubMed ID: 21761349
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
Weroha SJ; Li SA; Tawfik O; Li JJ
Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
[TBL] [Abstract][Full Text] [Related]
3. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats.
Li JJ; Weroha SJ; Lingle WL; Papa D; Salisbury JL; Li SA
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18123-8. PubMed ID: 15601761
[TBL] [Abstract][Full Text] [Related]
4. Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.
Akli S; Van Pelt CS; Bui T; Meijer L; Keyomarsi K
Cancer Res; 2011 May; 71(9):3377-86. PubMed ID: 21385896
[TBL] [Abstract][Full Text] [Related]
5. The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone.
Turan VK; Sanchez RI; Li JJ; Li SA; Reuhl KR; Thomas PE; Conney AH; Gallo MA; Kauffman FC; Mesia-Vela S
J Endocrinol; 2004 Oct; 183(1):91-9. PubMed ID: 15525577
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer.
Singh B; Chatterjee A; Ronghe AM; Bhat NK; Bhat HK
BMC Cancer; 2013 May; 13():253. PubMed ID: 23697596
[TBL] [Abstract][Full Text] [Related]
8. Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis.
Goepfert TM; Adigun YE; Zhong L; Gay J; Medina D; Brinkley WR
Cancer Res; 2002 Jul; 62(14):4115-22. PubMed ID: 12124350
[TBL] [Abstract][Full Text] [Related]
9. Effect of energy restriction on the expression of cyclin D1 and p27 during premalignant and malignant stages of chemically induced mammary carcinogenesis.
Zhu Z; Jiang W; Thompson HJ
Mol Carcinog; 1999 Apr; 24(4):241-5. PubMed ID: 10326860
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.
Bagheri-Yarmand R; Biernacka A; Hunt KK; Keyomarsi K
Cancer Res; 2010 Jun; 70(12):5074-84. PubMed ID: 20530685
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression.
Kovalchuk O; Tryndyak VP; Montgomery B; Boyko A; Kutanzi K; Zemp F; Warbritton AR; Latendresse JR; Kovalchuk I; Beland FA; Pogribny IP
Cell Cycle; 2007 Aug; 6(16):2010-8. PubMed ID: 17700064
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
Singh B; Shoulson R; Chatterjee A; Ronghe A; Bhat NK; Dim DC; Bhat HK
Carcinogenesis; 2014 Aug; 35(8):1872-80. PubMed ID: 24894866
[TBL] [Abstract][Full Text] [Related]
13. Novel insight in estrogen homeostasis and bioactivity in the ACI rat model of estrogen-induced mammary gland carcinogenesis.
Pemp D; Esch HL; Hauptstein R; Möller FJ; Zierau O; Bosland MC; Geppert LN; Kleider C; Schlereth K; Vollmer G; Lehmann L
Arch Toxicol; 2019 Jul; 93(7):1979-1992. PubMed ID: 31119341
[TBL] [Abstract][Full Text] [Related]
14. Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer.
Li JJ; Papa D; Davis MF; Weroha SJ; Aldaz CM; El-Bayoumy K; Ballenger J; Tawfik O; Li SA
Mol Carcinog; 2002 Jan; 33(1):56-65. PubMed ID: 11807958
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer.
Akli S; Zheng PJ; Multani AS; Wingate HF; Pathak S; Zhang N; Tucker SL; Chang S; Keyomarsi K
Cancer Res; 2004 May; 64(9):3198-208. PubMed ID: 15126360
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat.
Korkola JE; Wood GA; Archer MC
Breast Cancer Res; 1999; 1(1):88-94. PubMed ID: 11056683
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic transformation of mammary epithelial cells in rats is associated with decreased apoptotic cell death.
Shilkaitis A; Green A; Steele V; Lubet R; Kelloff G; Christov K
Carcinogenesis; 2000 Feb; 21(2):227-33. PubMed ID: 10657962
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
